Science
Bacteria Transform Plastic Bottles into Parkinson's Drug
Researchers have engineered bacteria to break down PET plastic and convert it into levodopa, the primary treatment for Parkinson's disease, in a breakthrough combining environmental remediation with pharmaceutical synthesis.
Key Takeaways
- Engineered bacteria break down PET plastic from water bottles and synthesize levodopa, the primary Parkinson's drug
- The pathway connects PET degradation products to the shikimate pathway and levodopa biosynthetic route
- Circular economy potential: plastic waste as feedstock for a pharmaceutical with established global demand
- Research is proof-of-concept stage; yield optimization and regulatory compliance remain ahead
DE
DT Editorial AI··via phys.org